Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells

Journal of Ocular Pharmacology and Therapeutics

Volumn 16, Issue 4, 2000, Pages 383-391

  Murata, M ^a   Kador, P F ^a   Sato, S ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL GROWTH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DOG; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION; NONHUMAN; PROLIFERATIVE RETINOPATHY; PROTEIN PHOSPHORYLATION; RETINA CAPILLARY;

EID: 0033841583     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2000.16.383     Document Type: Article

References (39)

1. The cystine-knot growth-factor superfamily
2. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
3. Molecular and biological properties of the vascular endothelial growth factor family of proteins
4. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
5. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
6. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factory by human retinal pigment epithelial cells
7. Hypoxic regulation of vascular endothelial growth factor in retinal cells
8. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
9. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model
10. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor
11. Vascular endothelial growth factor and the eye: Biochemical mechanisms of action and implications for novel therapies
12. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
13. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
14. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c- kit
15. Identification of a new endothelial cell growth factor receptor tyrosine kinase
16. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
17. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
18. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice
19. Different signal transduction properties of KDR and Fltl, two receptors for vascular endothelial growth factor
20. The pathway to signal achievement
21. Cell biology. Two major signaling pathways meet at MAP-kinase
22. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells
23. Vascular endothelial growth factor (VEGF) activates Raf-1, mitogen-activated protein (MAP) kinases, and S6 kinase (p90rsk) in cultured rat cardiac myocytes
24. Virally activated Ras cooperates with integrin to induce tubulogenesis in sinusoidal endothelial cell lines
25. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins
26. Experimental galactosemia produces diabetic-like etinopathy
27. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors
28. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors
29. Diabeteslike preproliferative retinal changes in galactose-fed dogs
30. Diabeteslike proliferative retinal changes in galactose-fed dogs
31. Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes
32. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein
33. In vitro interaction of astrocytes and pericytes with capillary-like structures of brain microvessel endothelium
34. Dimerization of cell surface receptors in signal transduction
35. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation
36. Sck interacts with KDR and Flt-1 via its SH2 domain
37. Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2
38. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth
39. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1)